Meeting the Clinical Needs of Patients
 |  |  |  |  |
|---|---|---|---|---|
 |
Dexonto™ 0.4%, is a topical formulation of dexamethasone for iontophoresis.
Diclofono™ 1.6%, is a topical formulation of diclofenac to be used with or without ultrasound.
Frotek™ 10%, is a topical formulation of ketoprofen.
Lidocidex™ is an injectable sterile formulation consisting of lidocaine and dexamethasone.
Lidomar™ is an injectable sterile formulation consisting of lidocaine and bupivicane.
Neuraptine™ 10%, is a topical formulation of gabapentin.
Nubratori RX currently has ten additional products in the pipeline designed for non-opiate pain control for orthopedics, neurologists, and others in the pain management health care sector.
For more information on any of these formulations, please contact us and also peruse the section on white papers and articles, found here.
Nubratori RX products are batch tested, validated, and put through the required stability and potency testing prior to being released to the market.
Let us know how we can help you.
381 Van Ness Ave Suite 1507, 1508 Torrance, CA 90501
